Frontiers in anti-inflammatory therapies - discussion

4 More presentations in this session

Targeting inflammasome axis and NLRP3 inhibitors and IL-1 blockade in cardiovascular disease

Professor P. Libby (Boston, US)

Slides Video

Targeting IL-6 signalling from biological rationale to cardiovascular outcome trials

Doctor P. Ridker (Boston, US)

Slides Video

Heart failure and immune-mediated syndrome: new insights and emerging targets

Professor J. Hill (Dallas, US)

Slides Video

Expanding frontiers in cardiometabolic therapy: SGLT2 inhibitors and GLP-1 receptor agonists

Professor V. Schini-Kerth (Strasbourg, FR)

Slides Video